Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization
Purpose: The aims of this study were to establish a joint population pharmacokinetic model for voriconazole and its N-oxide metabolite in immunocompromised patients, to determine the extent to which the CYP2C19 genetic polymorphisms influenced the pharmacokinetic parameters, and to evaluate and opti...
Saved in:
Main Authors: | SiChan Li (Author), SanLan Wu (Author), WeiJing Gong (Author), Peng Cao (Author), Xin Chen (Author), Wanyu Liu (Author), Liping Xiang (Author), Yang Wang (Author), JianGeng Huang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
by: SiChan Li, et al.
Published: (2021) -
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
by: Chao Mei, et al.
Published: (2023) -
Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023) -
Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients
by: Peng Cao, et al.
Published: (2022) -
Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
by: Yang Wang, et al.
Published: (2022)